Why BioMarin Pharmaceutical Inc. (BMRN) stock fell 5.9% intraday on Tuesday, November 3, 2026

BioMarin Pharmaceutical Inc. (BMRN) traded at $54.06 as of 10:31 AM ET, down 5.88% on Tuesday, November 3, 2026, on volume of 814,822 shares (0.4× its 3-month average); market value about $10.50B.

BMRN was among the stocks moving 5% or more in an earlier update that day; by the close it was no longer moving that much.

What happened: primary sources

Events Nexqual found for BMRN on Tuesday, November 3, 2026 or the trading day before (November 2, 2026):

• Nov 2, 2026: Reported Q3 2026 results: adjusted EPS $0.23 vs consensus −$0.11 (beat), revenue $1.02B. Guidance: Updated full-year 2026 revenue guidance to $3,800 million to $3,900 million. source
• Nov 3, 2026: RBC Capital: Target lowered, Sector Perform, price target $62 → $60
• Nov 3, 2026: Stifel: Target lowered, Hold, price target $70 → $66

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on BMRN

BMRN stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Earnings report: BMRN results, November 2, 2026. Other big moves that day: November 3, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 4, 2026 at 09:52 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 4, 2026 at 09:52 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt